245P Palbociclib combined with aromatase inhibitors (AIs) in women ≥75 years with oestrogen receptor positive (ER+ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer: A real-world multicentre UK study

Autor:	A. Proctor, M. Moe, K. Balachandran, Karen Desouza, Anna Stansfeld, F. Britton, Bilal A Tahir, Alicja Synowiec, Mark Verrill, Richard Simcock, Daniel Hills, Y. Shah, Pavel Bezecny, S. El Badri, M. Theodoulou, Caroline Wilson, T. Pigott, Anshu Wadhawan, Catherine Harper-Wynne
Rok vydání:	2021
Předmět:	biology business.industry Advanced breast Cancer Hematology Palbociclib medicine.disease Oncology biology.protein Cancer research Medicine Oestrogen receptor Aromatase business Human Epidermal Growth Factor Receptor 2
Zdroj:	Annals of Oncology. 32:S466
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.528
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::37c797cc2638ba50713355514baf05c0 https://doi.org/10.1016/j.annonc.2021.08.528 Zobrazit plný text záznamu